Protein nanovaccine confers robust immunity against Toxoplasma.
Protein nanovaccine confers robust immunity against Toxoplasma.
复制标题
DOI:
10.1038/s41541-017-0024-6
复制
发表时间:
2017
期刊:
影响因子:
9.2
通讯作者:
McLeod R
中科院分区:
文献类型:
--
作者:
El Bissati K;Zhou Y;Paulillo SM;Raman SK;Karch CP;Roberts CW;Lanar DE;Reed S;Fox C;Carter D;Alexander J;Sette A;Sidney J;Lorenzi H;Begeman IJ;Burkhard P;McLeod R
We designed and produced a self-assembling protein nanoparticle. This self-assembling protein nanoparticle contains five CD8+ HLA-A03-11 supertypes-restricted epitopes from antigens expressed during Toxoplasma gondii’s lifecycle, the universal CD4+ T cell epitope PADRE, and flagellin as a scaffold and TLR5 agonist. These CD8+ T cell epitopes were separated by N/KAAA spacers and optimized for proteasomal cleavage. Self-assembling protein nanoparticle adjuvanted with TLR4 ligand-emulsion GLA-SE were evaluated for their efficacy in inducing IFN-γ responses and protection of HLA-A*1101 transgenic mice against T. gondii. Immunization, using self-assembling protein nanoparticle-GLA-SE, activated CD8+ T cells to produce IFN-γ. Self-assembling protein nanoparticle-GLA-SE also protected HLA-A*1101 transgenic mice against subsequent challenge with Type II parasites. Hence, combining CD8+ T cell-eliciting peptides and PADRE into a multi-epitope protein that forms a nanoparticle, administered with GLA-SE, leads to efficient presentation by major histocompatibility complex Class I and II molecules. Furthermore, these results suggest that activation of TLR4 and TLR5 could be useful for development of vaccines that elicit T cells to prevent toxoplasmosis in humans. Toxoplasma gondii is the most common parasitic infection worldwide. It causes brain and eye damage as well as death. The organism is present in the brain of approximately two billion people worldwide. Although active infection can be treated, there is no cure. A vaccine is greatly needed. Herein, we demonstrate that we can produce a self-assembling protein nanoparticle (SAPN) with flagellin as a TLR5 ligand immune stimulating signal, and as a scaffold for CD8+ and CD4+ T cell-eliciting epitopes. We find this immunogen confers robust protection in our human HLA class I transgenic mouse model. Our SAPN contains peptides that elicit production of IFN-γ by CD8+ T lymphocytes from transgenic mice, as well as by CD4+ T cells. The SAPNs are further adjuvanted with a TLR4 ligand. Our adjuvanted, immunosense SAPN that combines stimuli for innate and adaptive immunity, presents an advancement in vaccine development that has considerable promise for protection against infections.
登录
查看更多内容
影响因子:
2.7
作者:
Cong, Hua;Mui, Ernest J.;Witola, William H.;Sidney, John;Alexander, Jeff;Sette, Alessandro;Maewal, Ajesh;El Bissati, Kamal;Zhou, Ying;Suzuki, Yasuhiro;Lee, Daniel;Woods, Stuart;Sommerville, Caroline;Henriquez, Fiona L.;Roberts, Craig W.;McLeod, Rima
通讯作者:
McLeod, Rima
影响因子:
6.7
作者:
Lindestam Arlehamn CS;McKinney DM;Carpenter C;Paul S;Rozot V;Makgotlho E;Gregg Y;van Rooyen M;Ernst JD;Hatherill M;Hanekom WA;Peters B;Scriba TJ;Sette A
通讯作者:
Sette A
影响因子:
5.8
作者:
Anderson, Ryan C.;Fox, Christopher B.;Vedvick, Thomas S.
通讯作者:
Vedvick, Thomas S.
影响因子:
5.4
作者:
de Alwis, Ruklanthi;Bangs, Derek J.;Weiskopf, Daniela
通讯作者:
Weiskopf, Daniela
影响因子:
8
作者:
El Bissati, Kamal;Chentoufi, Aziz A.;McLeod, Rima
通讯作者:
McLeod, Rima